Sept. 4, 2025 - Epoch Times
02:20
| 
| Time | Text |
|---|---|
| It appears that the secretary asked the director of the CDC to terminate some of these senior long-term staff that were insisting on basically controlling the agenda for the upcoming ACIP COVID subcommittee workgroup and what they would be allowed to consider, | |
| as they would investigate and make recommendations to the director of the CDC concerning the three COVID vaccine products that are currently on the agenda for discussion at the upcoming ACIP meeting, | |
| which Bobby has insisted occur in September and is now finally scheduled for the 18th and 19th of this month. | |
| So stay tuned. | |
| If you're enjoying the last week, you'll enjoy the week of the 17th and the 18th even more. | |
| Last week, the Secretary also announced that the emergency use authorization for the COVID products had finally been rescinded. | |
| The emergency medical emergency had been declared ended months ago, but they managed to kind of retain the EUA authorization for these products, even though there was no longer a medical emergency. | |
| And that's finally ended. | |
| And so now we have termination of that and three products authorized Moderna Pfizer and Novavax, you know, in short, for limited indications of basically elderly and populations at high risk of at least one high risk factor, undefined by the FDA what that meant, | |
| which is part of the remit now that's been tossed into the lap of the ACIP, because we're obligated by statute to advise the Secretary at the meeting following any FDA determination about a vaccine. |
Export Selection